SEC Form 4 research
| Issuer | Aimmune Therapeutics, Inc. |
|---|---|
| Tickers | AIMT |
| Reporting owners | 32 |
| Officers and directors | 12 |
| Last public filing | 2026-10-23 |
No matching recent records; this is not a statement about historical activity.
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.